Our Research Services
CERA Medical supports biomedical research across three integrated divisions: preclinical rodent studies, wet-lab molecular research, and biomedical data analysis. For every project we agree the scope, timeline, milestones, and deliverables in writing before work begins.
- Animal House VivariumPillar 01In Vivo • In Vitro • In Silico
Preclinical Studies
Rigorous efficacy, pharmacokinetic, and safety profiling in rodent disease models, validated cell cultures, and GPU-driven molecular simulations.
Core Capabilities & Methods- In Vivo Rodent Disease ModelsMus musculus SPF housing, behavioral tracking, neurotoxicity, and dose-response pharmacology.
- In Vitro Cell Assays & ScreeningPrimary cell cultures, glioblastoma models, cytotoxicity assays, and drug mechanism profiling.
- In Silico GPU Molecular DynamicsNVIDIA Tesla V100 molecular docking, target binding affinity estimation, and 100ns trajectory simulations.
- Ethical Protocol & IAEC OversightInstitutional Animal Ethics Committee oversight and GLP-aligned written study documentation.
Explore Topics - BSL-2 Lab CorePillar 02Genomics • Proteomics • Histology
Molecular Research
Quantitative molecular assays, immunoassay cascades, histology, and nucleic acid sequencing for translational biomedical research.
Core Capabilities & Methods- Quantitative RT-qPCR & PCRPrecision gene expression profiling, primer design, and validated target RNA/DNA quantitation.
- ELISA Panels & Western BlottingQuantitative biomarker detection, protein electrophoresis, and validated antibody probing.
- Histopathology & Fluorescent ImagingH&E, Nissl tissue staining, immunohistochemistry (IHC), and high-resolution fluorescence microscopy.
- Sanger Sequencing & ExtractionHigh-yield DNA/RNA extraction protocols followed by Sanger capillary sequencing verification.
- GPU Compute InfrastructurePillar 03Metagenomics • Biostatistics • Omics
Biomedical Data Analysis
End-to-end computational biology pipelines, clinical biostatistics, and PRISMA systematic evidence synthesis for publication-ready impact.
Core Capabilities & Methods- Metagenomics & Microbiome ProfilingWhole-genome shotgun sequencing, 16S/ITS rRNA profiling, and alpha/beta taxonomic diversity analysis.
- Health & Clinical BiostatisticsLongitudinal cohort analytics, clinical trial biostatistics, and survival modeling for clinical studies.
- Omics & Transcriptomics PipelinesRNA-seq differential expression, functional pathway enrichment, and public dataset re-analysis.
- PRISMA Evidence SynthesisSystematic reviews, meta-analyses, and publication-ready scientific dossiers adhering to PRISMA.
Need to initiate a study protocol?
Tell us what you are studying, candidate compounds, samples or omics data involved. We provide agreed written scopes, ethical oversight, and transparent revision rounds.